"Revolutionizing Weight Loss: The Impact of Ozempic, Wegovy, and Their Competitors"

GLP-1 weight-loss drugs like Ozempic and Wegovy are gaining popularity and could potentially create a $100 billion market, leading to significant economic impacts such as improved labor market activity, healthier populations, and reduced healthcare costs. The emergence of these drugs could lead to a global economic boom, particularly in countries with high obesity rates. However, uncertainties remain regarding side effects, costs, and supply. Additionally, the convergence of weight-loss drugs and artificial intelligence technology may further revolutionize the healthcare sector.